Print

Vaccine May Prevent Multiple Sclerosis, Sapienza University Study  
12/5/2013 8:39:23 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

An anti-tuberculosis vaccine could prevent multiple sclerosis, early research suggests. A small-scale study by researchers at the Sapienza University of Rome has raised hopes that the disease can be warded off when early symptoms appear. More research is needed before the BCG vaccine can be trialled on MS patients.

Hey, check out all the research scientist jobs. Post your resume today!

//-->